|

Reports from ASH and ASCO-GI
LYMPHOMA: first-line treatment for advanced disease
Stephen Couban, MD, FRCPC
MULTIPLE MYELOMA: outcome improvements using combination
regimens in older patients
Shamin Wadiwalla, MD; Tony Reiman, MD, SM, FRCPC
COLON CANCER: impact of KRAS biomarker in therapy selection
Ralph Wong, MD, FRCPC
COLON CANCER: recent advances in adjuvant therapy
Timothy Asmis, MD, FRCPC
PANCREATIC CANCER: novel screening tools
Sharlene Gill, MD, MPH, FACP, FRCPC
PSYCHOSOCIAL CARE: evidence for end-of-life planning
Ester Green RN, MSc(T); Bejoy Thomas, MPhil, PhD
More>>
|